- Home
- ACVA vs AMLX Comparison
ACVA vs AMLX Comparison
Compare ACVA & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$5.13
HOLD
Current Price
$13.83
Company Overview
Basic Information| Metric | ACVA | AMLX |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ACVA | AMLX |
|---|---|---|
| Price | $5.13 | $13.83 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 9 |
| Target Price | $12.04 | ★ $19.56 |
| AVG Volume (30 Days) | ★ 3.8M | 803.1K |
| Earning Date | 05-25-2026 | 06-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 18.75 | ★ 65.46 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $759,606,000.00 | $380,786,000.00 |
| Revenue This Year | $13.99 | N/A |
| Revenue Next Year | $12.62 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 19.22 | ★ 1612.94 |
| 52 Week Low | $4.45 | $3.11 |
| 52 Week High | $17.16 | $17.49 |
Technical Indicators
Market Signals| Indicator | ACVA | AMLX |
|---|---|---|
| Relative Strength Index (RSI) | 33.53 | 46.18 |
| Support Level | $4.95 | $13.28 |
| Resistance Level | $8.37 | $15.27 |
| Average True Range (ATR) | 0.47 | 0.93 |
| MACD | 0.01 | -0.07 |
| Stochastic Oscillator | 29.05 | 10.53 |
Price Performance
Historical Comparison ACVA
AMLX
About ACVA ACV Auctions Inc.
ACV Auctions Inc is a mobile platform for wholesale car auctions. The company provides a digital marketplace for wholesale vehicle transactions and data services that offer transparent and accurate vehicle information for customers.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.